Literature DB >> 17358051

Synthesis of a new class of druglike angiotensin II C-terminal mimics with affinity for the AT2 receptor.

Jennie Georgsson1, Christian Sköld, Milad Botros, Gunnar Lindeberg, Fred Nyberg, Anders Karlén, Anders Hallberg, Mats Larhed.   

Abstract

Four tripeptides corresponding to the C-terminal region of angiotensin II were synthesized. One of these peptides (Ac-His-Pro-Ile) showed moderate binding affinity for the AT2 receptor. Two aromatic histidine-related scaffolds were synthesized and introduced in the tripeptides to give eight new peptidomimetic structures. Three of the new peptide-derived druglike molecules exhibited selective, nanomolar affinity for the AT2 receptor. These ligands may become lead compounds in the future development of novel classes of selective AT2 receptor agonists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17358051     DOI: 10.1021/jm0613469

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  10 in total

Review 1.  Natural products as sources of new drugs over the 30 years from 1981 to 2010.

Authors:  David J Newman; Gordon M Cragg
Journal:  J Nat Prod       Date:  2012-02-08       Impact factor: 4.050

2.  Angiotensin II type 2 receptor promotes adipocyte differentiation and restores adipocyte size in high-fat/high-fructose diet-induced insulin resistance in rats.

Authors:  Michaël Shum; Sandra Pinard; Marie-Odile Guimond; Sébastien M Labbé; Claude Roberge; Jean-Patrice Baillargeon; Marie-France Langlois; Mathias Alterman; Charlotta Wallinder; Anders Hallberg; André C Carpentier; Nicole Gallo-Payet
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-11-13       Impact factor: 4.310

Review 3.  The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target.

Authors:  U Muscha Steckelings; Robert E Widdop; Edward D Sturrock; Lizelle Lubbe; Tahir Hussain; Elena Kaschina; Thomas Unger; Anders Hallberg; Robert M Carey; Colin Sumners
Journal:  Pharmacol Rev       Date:  2022-10       Impact factor: 18.923

4.  AT2 Receptor-Interacting Proteins ATIPs in the Brain.

Authors:  Sylvie Rodrigues-Ferreira; Erwann le Rouzic; Traci Pawlowski; Anand Srivastava; Florence Margottin-Goguet; Clara Nahmias
Journal:  Int J Hypertens       Date:  2013-01-23       Impact factor: 2.420

5.  Angiotensin II, a Neuropeptide at the Frontier between Endocrinology and Neuroscience: Is There a Link between the Angiotensin II Type 2 Receptor and Alzheimer's Disease?

Authors:  Nicole Gallo-Payet; Marie-Odile Guimond; Lyne Bilodeau; Charlotta Wallinder; Mathias Alterman; Anders Hallberg
Journal:  Front Endocrinol (Lausanne)       Date:  2011-08-26       Impact factor: 5.555

6.  A Series of Analogues to the AT2R Prototype Antagonist C38 Allow Fine Tuning of the Previously Reported Antagonist Binding Mode.

Authors:  Rebecka Isaksson; Jens Lindman; Johan Wannberg; Jessica Sallander; Maria Backlund; Dhaniel Baraldi; Robert Widdop; Mathias Hallberg; Johan Åqvist; Hugo Gutierrez de Teran; Johan Gising; Mats Larhed
Journal:  ChemistryOpen       Date:  2019-01-24       Impact factor: 2.911

Review 7.  AT2 receptors: functional relevance in cardiovascular disease.

Authors:  Emma S Jones; Antony Vinh; Claudia A McCarthy; Tracey A Gaspari; Robert E Widdop
Journal:  Pharmacol Ther       Date:  2008-08-31       Impact factor: 12.310

8.  Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists.

Authors:  Silvana Vasile; Anders Hallberg; Jessica Sallander; Mathias Hallberg; Johan Åqvist; Hugo Gutiérrez-de-Terán
Journal:  Biomolecules       Date:  2020-04-23

9.  The Angiotensin II Type 2 Receptor in Brain Functions: An Update.

Authors:  Marie-Odile Guimond; Nicole Gallo-Payet
Journal:  Int J Hypertens       Date:  2012-12-25       Impact factor: 2.420

10.  N-Aryl Isoleucine Derivatives as Angiotensin II AT2 Receptor Ligands.

Authors:  Malte Behrends; Charlotta Wallinder; Anna Wieckowska; Marie-Odile Guimond; Anders Hallberg; Nicole Gallo-Payet; Mats Larhed
Journal:  ChemistryOpen       Date:  2014-03-13       Impact factor: 2.911

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.